Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PISTIAS trial of evolocumab plus statin therapy for symptomatic intracranial artery stenosis
ChiCTR2300068868Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of evolocumab, rosuvastatin, atorvastatin and ezetimibe in cerebral arteriosclerosis, ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Plaque burden. Started Aug 2023; status: recruiting.
02
Drugs
evolocumabrosuvastatinatorvastatinezetimibe
03
Conditions
cerebral arteriosclerosisischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on ChiCTR2300068868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068868.